Articles by Disease (Gallbladder Cancer)

Inhibitors of NMT: A New Class of Chemotherapeutic Drugs

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1
Page: 347-354
Author(s): Gagan Bajaj, Anuraag Shrivastav, Ponniah Selvakumar, Mohammed Khysar Pasha, Yanjie Lu, Jonathan R Dimmock and Rajendra K Sharma

Role of Progastrins and Gastrins and Their Receptors in GI and Pancreatic Cancers: Targets for Treatment

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2345-2358
Author(s): William Rengifo-Cam and Pomila Singh

The Adipose Tissue as a Source of Vasoactive Factors

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2
Page: 197-208
Author(s): G. Frühbeck

Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3
Page: 43-61
Author(s): G. Coruzzi, A. Menozzi and G. Dobrilla

Cholecystokinin Antagonists A New Way to Improve the Analgesia from Old Analgesics?

Journal: Current Pharmaceutical Design
Volume: 10
Page: 303-314
Author(s): Gary McCleane

Design of β-turn Based Therapeutic Agents

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1209-1224
Author(s): K. Kee Suat and Seetharama D.S. Jois

Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1013-1022
Author(s): B. C. Yegen

CCK1R Agonists: A Promising Target for the Pharmacological Treatment of Obesity

Journal: Current Topics in Medicinal Chemistry
Volume: 3
Page: 837-854
Author(s): Jerzy R. Szewczyk and Chris Laudeman

The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance

Journal: Current Pharmaceutical Design
Volume: 9
Page: 627-641
Author(s): Ildiko Antal Zimanyi and Mary Ann Pelleymounter

Novel Approaches to Cancer Therapy Using Oncolytic Viruses

Journal: Current Molecular Medicine
Volume: 3
Page: 61-71
Author(s): S. F. Stanziale and Y. Fong